$
0.000
0.000(0.000%)
  • Overview
  • Forecast
  • Valuation
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
23.660
Open
23.310
VWAP
23.15
Vol
715.31K
Mkt Cap
2.85B
Low
22.870
Amount
16.56M
EV/EBITDA(TTM)
70.97
Total Shares
119.32M
EV
2.40B
EV/OCF(TTM)
21.93
P/S(TTM)
1.69
Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, improve patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The platform supports multiple provider types, enables scalable operations, and delivers patient centric in-person and virtual access to care, quality metrics, and lower cost of care. It provides management services to each Medical Group though a local management services organization.
Show More

Market Estimates

Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2025Q2
FY2025Q1
467.46M
+6.74%
--
--
457.43M
+8.31%
--
--
451.00M
+8.61%
--
--
Estimates Revision
The market is revising Downward the revenue expectations for Privia Health Group, Inc. (PRVA) for FY2025, with the revenue forecasts being adjusted by -1.29% over the past three months. During the same period, the stock price has changed by 4.17%.
Revenue Estimates for FY2025
Revise Downward
down Image
-1.29%
In Past 3 Month
Stock Price
Go Up
up Image
+4.17%
In Past 3 Month
18 Analyst Rating
up Image
27.51% Upside
Wall Street analysts forecast PRVA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PRVA is 29.94 USD with a low forecast of 23.00 USD and a high forecast of 40.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
17 Buy
1 Hold
0 Sell
Strong Buy
up Image
27.51% Upside
Current: 23.480
sliders
Low
23.00
Averages
29.94
High
40.00
JMP Securities
Constantine Davides
Buy
Reiterates
$29
2025-04-28
New
Reason
Baird
Michael Ha
Buy
Maintains
$24 → $26
2025-04-15
Reason
Baird analyst Michael Ha raised the firm's price target on Privia Health to $26 from $24 and keeps an Outperform rating on the shares. The firm sees minimal incremental buyers of stocks in the managed care and healthcare facilities group until the policy overhang clears. Baird does not not expect guidance raises as it believes companies will maintain 2025 "conservatism and cushion" given potential Part D and macro headwinds that may evolve later this year.
Needham
Matthew Sheerin
Strong Buy
Reiterates
$30
2025-04-10
Reason
Truist Securities
Jailendra Singh
Strong Buy
Maintains
$27 → $28
2025-04-10
Reason
Truist lowered the firm's price target on Privia Health to $28 from $30 and keeps a Buy rating on the shares as part of a broader research note previewing Q1 results in the Healthcare IT industry. The industry is typically shielded from macro uncertainty, but tariffs and concerns around an economic slowdown have created broader market uncertainty, which is never good for a high-beta highly volatile group like HCIT/Digital Health/Payviders, the analyst tells investors in a research note. Truist adds that while HCIT companies may not be directly exposed to new tariffs, several of these companies serve end markets - hospitals, pharma, etc. - which are likely to see either some direct impact on their supply chain costs or could decide to slow down on their investments.
Barclays
Andrew Mok
Hold
Maintains
$21 → $23
2025-04-10
Reason
Barclays raised the firm's price target on Privia Health to $23 from $21 and keeps an Equal Weight rating on the shares as part of a Q1 earnings preview for the managed care space.
Needham
Ryan MacDonald
Strong Buy
Reiterates
$30
2025-03-21
Reason

Valuation Metrics

The current forward P/E ratio for Privia Health Group Inc (PRVA.O) is 97.32, compared to its 5-year average forward P/E of 40.93. For a more detailed relative valuation and DCF analysis to assess Privia Health Group Inc 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
40.93
Current PE
97.32
Overvalued PE
362.96
Undervalued PE
-281.10

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average EV/EBITDA
39.56
Current EV/EBITDA
22.36
Overvalued EV/EBITDA
60.82
Undervalued EV/EBITDA
18.30

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PS
2.04
Current PS
1.52
Overvalued PS
2.96
Undervalued PS
1.13

Financials

Annual
Quarterly
FY2024Q4
YoY :
+4.55%
460.90M
Total Revenue
FY2024Q4
YoY :
+102.66%
7.78M
Operating Profit
FY2024Q4
YoY :
+130.94%
5.37M
Net Income after Tax
FY2024Q4
YoY :
+50.00%
0.03
EPS - Diluted
FY2024Q4
YoY :
+16.73%
74.80M
Free Cash Flow
FY2024Q4
YoY :
+18.46%
10.01
Gross Profit Margin - %
FY2024Q4
YoY :
+29.16%
6.29
FCF Margin - %
FY2024Q4
YoY :
+118.87%
1.16
Net Margin - %
FY2024Q4
YoY :
-45.61%
2.23
ROIC

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
846.3K
USD
7
3-6
Months
0.0
USD
0
6-9
Months
2.5M
USD
1
0-12
Months
314.8K
USD
3
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
7
9.3M
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
800.0K
Volume
2
Bought
0-3
0
0.0
Volume
Months
3-6
1
378.3K
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

PRVA News & Events

Events Timeline

2025-04-17 (ET)
2025-04-17
14:37:35
MCOs' 'mixed messages' creating volatility in value-based care, says Truist
select
2025-04-09 (ET)
2025-04-09
09:08:01
Privia Health enters Arizona in partnership with Integrated Medical Services
select
2025-02-27 (ET)
2025-02-27
06:23:10
Privia Health sees FY25 revenue $1.08B-$1.09B , consensus $1.89B
select
Sign Up For More Events

News

4.0
04-20Business Insider
Truist Financial Sticks to Their Buy Rating for Privia Health Group (PRVA)
4.0
04-15Benzinga
Assessing Privia Health Gr: Insights From 10 Financial Analysts
6.0
04-10Benzinga
Barclays Maintains Equal-Weight on Privia Health Gr, Raises Price Target to $23
Sign Up For More News

FAQ

arrow icon

What is Privia Health Group Inc (PRVA) stock price today?

The current price of PRVA is 23.48 USD — it has increased 0.3 % in the last trading day.

arrow icon

What is Privia Health Group Inc (PRVA)'s business?

arrow icon

What is the price predicton of PRVA Stock?

arrow icon

What is Privia Health Group Inc (PRVA)'s revenue for the last quarter?

arrow icon

What is Privia Health Group Inc (PRVA)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Privia Health Group Inc (PRVA)'s fundamentals?

arrow icon

How many employees does Privia Health Group Inc (PRVA). have?

arrow icon

What is Privia Health Group Inc (PRVA) market cap?